The new company aims to combine with a business with unique technology for healthcare, mobility, financial services or consumer marketplaces. $ Volume: $100.0 mil: Manager / Joint Managers: Stifel/ H.C. Wainwright & Co. CO-Managers: Expected To Trade: The Australian Company disclosed that the transaction is expected to generate gross proceeds of nearly US$403 million of cash, with the assumption of minimal redemptions by the public stockholders of DCRN. Chinese e-cigarette maker RLX Technology Inc. has priced its U.S. initial public offering above a marketed range at $12 a share, according to a person familiar with … The sector took in $7.739 billion in equity funding in 2019, just edging past the previous high of $7.715 billion it reached in 2018. -2.81% ~ $ 12.09 | DCRC - Decarbonization Plus Acquisition Corporation III (Pre-Deal) -2.81% ~ $ 9.70 | EBAC - European Biotech Acquisition Corp. (Pre-Deal) -2.67% ~ $ 13.13 | THCB - … Gossamer Bio – $317 Million IPO. Today's new IPOs traded down, as expected, in spite of friendlier warrant coverage and overfunded trust (in the case of Aries): . Virtuoso Acquisition Corp. 180 1/2 12/29/20 Westport, CT Digital Media 15. Eduardo has over 25 years of senior management and board experience in the biopharmaceutical sector, having held the position of CEO at Nordic Nanovector, TiGenix and Cellerix. From PitchBook. Gainers. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Company profiles of Special Purpose Acquisition (SPAC) or blank check company has no commercial operations and raises capital via an initial public offering (IPO) for the purpose of buying another company. Europe-based companies still accounted for a tiny minority of IPOs and continued to favor US listings over domestic ones. Former Tesla director Bernard Tse co-founded the company in 2007 as Atieva. Kanzhun Limited’s US$912 Million Initial Public Offering June 16, 2021 4 Keppel Infrastructure Fund Management Pte. GO Acquisition Corp. announced the pricing of its initial public offering of 50,000,000 units at a price of $10.00 per unit. The biotech markets somewhat underperformed, with the NBI, BTK and XBI all closing down 4%, 9% and 3%, respectively. A special purpose acquisition corporation, commonly known as a "SPAC," and formally a "development stage company," is a corporation formed for the purpose of raising capital through an initial public offering ("IPO") of its securities, in order to fund an acquisition of an existing operating company or companies. EUROPEAN BIOTECH ACQUISITION A Aktie Orderbuch Xetra - Bid-Ask Volumen mit aktuellen Kursen - Times & Sales zu A2QRY6 - KYG3167F1101 - Realtimekurse The company … iFAST does not allow new purchases or transfer-in of OTC shares. RA Capital’s special purpose acquisition company Therapeutics Acquisition has filed a registration with the US Securities and Exchange Commission to raise up to USD 100.00 million in an initial public offering (IPO). Toronto Stock Exchange, TSX Venture Exchange TMX Group today announced its financing activity on Toronto Stock Exchange and TSX Venture Exchange for April 2021 . Panacea Acquisition Corp. II Announces Pricing of $150,000,000 Initial Public Offering. Eduardo has over 25 years of senior management and board experience in the biopharmaceutical sector, having held the position of CEO at Nordic Nanovector, TiGenix and Cellerix. Splash Beverage Group, Inc. Warrants to purchase one whole share of Common Stock at an exercise price of $4.60. Orion Biotech Opportunities Corp., a special purpose acquisition company sponsored by affiliates of MSD Partners, L.P. and Panacea Venture Healthcare in its $200 million initial public offering; MSD Acquisition Corp., a special purpose acquisition company sponsored by an affiliate of MSD Partners, L.P., in its $575 million initial public offering As readers will note below, IPOs in the biotech space can surge over 300% within just a year or two. E alan.mendelson@lw.com. Represented an insurance company in its $98 million Up-C initial public offering.° Represented an investment bank in At-The-Market offering program for a public biotech company.° Represented an investment bank in $1.71 billion secondary offering of public company stock by certain selling stockholders affiliated with private equity firm.° The Historical Biotech IPO Database below tracks most listings over at least the previous 12 months. This figure climbs to 11.5 million units in the event of any over-allotments. The units will be listed on The Nasdaq Capital Market LLC (the "Nasdaq") and trade under the symbol "ORIAU" beginning May 13, 2021.. Each unit consists of one of the Company… A Baltimore-based biomedical investment firm is one of the partners on a blank check company that debuted on the Nasdaq this week. The overall markets were stable this week with the NASDAQ, DJI and S&P 500 closing down 3%, up 1% and down 1%, respectively. Lucid Motors is an EV company headquartered in Newark, California. Advised the Conflicts Committee of the Board of Directors of TC PipeLines GP, Inc. on the acquisition of 49% equity interest in Iroquois Gas Transmission System and 12% equity interest in Portland Natural Gas Transmission System from TransCanada Corporation. Upon completion of the transaction 4D will apply for its American Depositary Shares to be admitted to trading on NASDAQ. Special Purpose Acquisition Company (SPAC) 000000000 00000000: 25-Jun-2019: 000000000000000000: Drug Discovery: 0000000 0000000 00. EUROPEAN BIOTECH ACQUISITION CORP EVENTIKO INC EVERCOMMERCE INC EWPG HOLDING AB Exa Corp. EXAGEN DIAGNOSTICS INC EXCELLERANT INC EXCELSA ACQUISITION CORP Exco partners l.p. EXCOLERE ACQUISITION CORP EXENT CORP Exmar Energy Partners Lp Expedite 4 Inc. Insights about top trending companies, startups, investments and M&A activities, notable investors of these companies, their management team, and recent news are also included. Another $650 million will come from a private investment in public equity (PIPE). The company was founded in 2021 and is based in Amsterdam, the Netherlands. 52 … It was total of US$6.5 billion in 2018. Aeon Acquisition: The blank check company, formed by The Aeon Group, has filed to raise up to $125 million in an IPO. The company has taken an illiquid and antiquated asset class and given it a much-needed 21 st century facelift. SEC Form S-1 is a registration filing form for companies to complete registration of securities offering under the Securities Act of 1933 [] (see also, 15 USC Ch. Davis Polk advised European Biotech Acquisition Corp. on its $120 million initial public offering of 12,000,000 units. Each unit had an initial offering price of $10 and consists of one Class A ordinary share and one-third of one redeemable warrant. Lucid Motors IPO: The Business. CPE News (7/20/2020) – NextPoint Acquisition Corp. (NAC), a newly organized British Columbia special purpose acquisition corporation (SPAC), has filed a preliminary prospectus for an initial public offering (IPO) of Class A Restricted Voting Units at US $10 per unit for gross proceeds of US $200 million. Underwriters' overallotment option is … New Providence Acquisition Corp (NPA) Shareholder Meeting to Extend Deadline for Business Combination. Hennessey Capital’s closed at $11.13 on Thursday, up about 10% from its April IPO price of $10 per share. Verve Therapeutics Inc. () is set to go public Thursday, after the Massachusetts-based biotechnology company's upsized initial public offering priced overnight above the expected range to value the company at about $832.6 million.Verve, which focuses on genetic medicines for cardiovascular disease, said it sold 14.04 million shares in the IPO, which priced at $19 a share, to raise $266.7 million. > EBAC IS THE FIRST HEALTHCARE SPAC TO EXCLUSIVELY FOCUS ON EUROPEAN BIOTECH > EDUARDO BRAVO TO JOIN LSP AS A PARTNER AND BECOME EBAC’S CEO LSP, the leading European life sciences investor, today announces the closing of the upsized $120 million Nasdaq IPO of European Biotech Acquisition Corporation (EBAC). ... European Biotech Acquisition Corp Cl A Full Profile. The company is currently valued at $1.9 billion and … The fundraising is the third largest biotech IPO in 2021, after Sana Biotechnology's $588 million listing and Recursion Pharmaceuticals' $436 million offering. CPE News (4/14/2021) – WD Growth I Corp., a newly organized G-Corp sponsored by WD Investments I Inc., has filed a preliminary prospectus in connection with an initial public offering (IPO) of Class A Restricted Voting Units priced at an offering price of $3.00 per Class A Restricted Voting Unit.. As a G-Corp, WD Growth I intends to raise gross proceeds of not more than $30,000,000. You may contact the dealing team at 6439 8007 (US Exchange) and 6439 8008 (SGX & HKEX) if you wish to sell your existing OTC shares that are currently held with us. Alan C. Mendelson. Omega Alpha SPAC Prices IPO. Panacea units traded down -0.86% to … Recent IPOs of common stocks. Kismet Acquisition Three Corp. announced the pricing of its $250 million IPO this evening and its units are expected to begin trading on the Nasdaq under the symbol “KIIIU,” Thursday, February 18. A newly incorporated blank check company: 2021-02-17: Forum Merger IV Corp: Delray Beach, FL: $300.0 mil. At the proposed deal size, European Biotech Acquisition would command a market value of $129 million. The company is led by Chairman Martijn Kleijwegt, the founder and Managing Partner of LSP, one of Europe's largest healthcare investment firms, and CEO Eduardo Bravo, who previously served as Interim CEO of OncoDNA and CEO of Nordic Nanovector. Contact: John Jannarone, Editor-in-Chief. Source: The Wall Street Journal. Twitter: @IPOEdge The Apothecary Shoppe (Las Vegas) 11-Dec-2018: Merger/Acquisition: Pharmaceuticals: 0000000 0000000 00. SPAC Stocks. 000 0000000 000000: 21-Jun-2019: 000000000000000000: Other Healthcare Services: 0000000 0000000 00. Frontier Acquisition Corporation, a special purpose acquisition company formed for the purpose of entering into a combination with one or more biotech businesses, has announced the pricing of its initial public offering of $200 million. Editor@IPO-Edge.com. Frazier Lifesciences Acquisition Corporation has recently filed paperwork with the SEC as part of its IPO process. This list of companies and startups in European Union (EU) in the biotechnology space provides data on their funding history, investment activities, and acquisition trends. The Hong Kong-based company, which has … This product is not available for online trading on our platform as it is traded Over-The-Counter (OTC). The BioPharmCatalyst Biotech Stock IPO Calendar gives a brief rundown of upcoming biotech initial public offerings. The Historical Biotech IPO Database below tracks most listings over at least the previous 12 months. As readers will note below, IPOs in the biotech space can surge over 300% within just a year or two. Uber Technologies $8.1 Billion IPO. In terms of the number of investors active in the space, the leading European Biotech location is Switzerland as a country which hosts 14 Biotech investors active in 2020, with France (12) and Germany (12) hot on its heels. The company … EToro announced the acquisition on March 16, 2021. The month of February also saw a new record set for SPAC IPOs filed with 96 SPAC IPOs raising over $30 billion. Advised TAC Acquisition Corporation in a $120 million initial public offering. Therapeutics Acquisition Corp. (TXACU) filed its S-1 yesterday for what we believe will be a highly-anticipated offering. Highlights & lowlights, financing, deals, IPOs, M&As, approvals, newsflow, stock performances, valuations, COVID-19 obviously, plus an outlook for 2021. Summit Healthcare Acquisition Corp. is a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, which we refer to as our initial business combination. Of this new investment, 60 percent went to Belgium, Switzerland, and the United Kingdom. The team behind ex-ASX listed biotech Viralytics – which was bought by global pharma giant Merck in 2018 for $502 million – are back with a new IPO. LifeSci Acquisition Corp. (Nasdaq: LSAC, LSACU AND LSACW) is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities, pursuing targets that are focused on healthcare innovation in North America or Europe. Announces Pricing of $125 Million Initial Public Offering. June 2017. In recent weeks, we’ve had European biotechs queuing up to enter the US Nasdaq Stock Market with an IPO, including the Belgian immuno-oncology firm iTeos Therapeutics, the UK gene therapy biotech Freeline Therapeutics, and the German mRNA company CureVac, which is … The Accelerate Arbitrage Fund (TSX: ARB) provides exposure to SPAC arbitrage and merger arbitrage investment strategies. Enjoy! The company was created through a partnership between New York-based healthcare fund manager HealthCor Capital … Total investment in Europe’s biotech firms has tripled over the past decade and more than doubled in just the past few years (Exhibit 5)—from $5.1 billion (2005 to 2011) to $11.9 billion (2012 to 2018). Proceeds from the agreement. ShockWave Medical – $111 Million IPO. NEW YORK, May 12, 2021 /PRNewswire/ -- Orion Biotech Opportunities Corp. (the "Company") today announced the pricing of its initial public offering ("IPO") of 20,000,000 units at a price of $10.00 per unit. The Company is valued at ~US$1.2 billion. Parties: EUROPEAN BIOTECH ACQUISITION CORP. | CONTINENTAL STOCK TRANSFER TRUST COMPANY | EUROPEAN BIOTECH ACQUISITION CORP | LSP Sponsor EBAC BV Law Firm: Davis Polk Document Date: 3/18/2021 Governing Law:New York Lucid Motors’ market is primarily U.S. with some European exports. Orion Biotech Opportunities Corp., a special purpose acquisition company formed by MSD Partners and Panacea Venture, pulled off a $200 million IPO. Retired Partner. NEW YORK, Jan. 21, 2021 /PRNewswire/ -- European Sustainable Growth Acquisition Corp. (the "Company") announced today that it priced its initial public offering … The new company aims to combine with a European life sciences targe t with a focus on those nearing potential breakthroughs. The top three European biotech IPOs were all on US exchanges. LifeSci Acquisition Corp. (Nasdaq: LSAC, LSACU AND LSACW) is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities, pursuing targets that are focused on healthcare innovation in North America or Europe. The VIX closed up 4%, sitting at 3.58 as of market close on 5/6. A newly organized blank check company: 2021-02-17: Hayward Holdings, Inc. Berkeley Heights, NJ: $880.1 mil. Orion Biotech Opportunities Corp., a special purpose acquisition company sponsored by affiliates of MSD Partners, L.P. and Panacea Venture Healthcare in its $200 million initial public offering; MSD Acquisition Corp., a special purpose acquisition company sponsored by an affiliate of MSD Partners, L.P., in its $575 million initial public offering Biotech Acquisition Company 200 1/2 12/31/20 New York, NY Health Tech ... Ltd 200 0 12/31/20 Hong Kong Generalist 14. LSP Founder and Managing Partner Martijn Kleijwegt will become EBAC’s Chairman and Mark Wegter will be joining EBAC’s … The second half of the year was a marked improvement on the first half, but that was linked to the timing of a couple of large-scale transactions. EarlyBirdCapital, Inc. is a member of FINRA, NQX, and SIPC.All securities are offered through EarlyBirdCapital, Inc. Securities Investor Protection Corporation (SIPC) insures the accounts of our clients for up to $500,000 each customer, subject to limitation of $100,000 from claims for cash balances. The BioPharmCatalyst Biotech Stock IPO Calendar gives a brief rundown of upcoming biotech initial public offerings. He is the CEO of EBAC (European Biotech Acquisition Corporation), a Nasdaq’s listed SPAC sponsored by LSP with focus on European biotech companies. In addition to taking the traditional IPO route, companies such as Therapeutics Acquisition choose the SPAC (Special Purpose Acquisition Company) model to go public. Apex Technology Acquisition Corp. (NASDAQ: APXT, "Apex"), a publicly-traded special purpose acquisition company, and AvePoint, Inc. ("AvePoint"), the largest data … Recent IPOs of common stocks. EFFECTOR Therapeutics will hit the stock market by merging with blank check company Locust Walk Acquisition. NEW YORK, May 12, 2021 /PRNewswire/ -- Orion Biotech Opportunities Corp. (the "Company") today announced the pricing of its initial public offering ("IPO") of 20,000,000 units at a price of $10.00 per unit. Claim your 1-week free trial to StreetInsider Premium here. Die European Biotech Acquisition Corporation Cons of 1 Shs -A- + 1-3 Wt Aktie wird unter der ISIN KYG3167F1101 an den Börsen Frankfurt, NASDAQ, Bats und NDB gehandelt. May 4, 2017. www.IPO-Edge.com. Success was defined as startups that either were successfully listed on public markets (IPO), were acquired (majority or 100% acquisitions), or had a … T +1.650.463.4693. A special purpose acquisition company (SPAC) is an alternative to the traditional initial public offering (IPO) process that public companies use to raise capital and having its stock traded publicly on a major stock exchange. Alan Mendelson retired from the partnership on December 31, 2020. 2A, Part 77.This act, also known as the Truth in Securites Act was inacted to bring greater transparency to securities. BOSTON-- ( BUSINESS WIRE )-- Omega Fund Management ’s special purpose acquisition corporation, Omega Alpha SPAC, announced the pricing of its initial public offering of 12,000,000 Class A ordinary shares, par value $0.0001, at a price to the public of $10.00 per share, for aggregate gross proceeds of $120,000,000. ABG currently manages or advises over $2.5 billion in healthcare assets, with a portfolio of what we believe to be some of the world’s most novel life science companies and technologies based in the United States, Europe and China. Therapeutics Acquisition Corp. (July 2020) (targeting biotechnology sector) Targeting a Number of Industries, including Healthcare/Life Sciences: — Capstar Special Purpose Acquisition Corp. (July 2020) (targeting consumer, healthcare, technology, media or telecommunications industries) — Galileo Acquisition Corp. (Oct. 2019) A special purpose acquisition company (“SPAC”) is a New York Stock Exchange (“NYSE”) or NASDAQ-listed shell company through which a team of sponsors raises capital in an initial public offering (“IPO”) for an unspecified future acquisition of an operating company, which in turn can quickly become NYSE or NASDAQ-listed upon merging with the SPAC. On Nov. 30, 2020, Lion announced a merger with Northern Genesis Acquisition Corp. (NASDAQ: NGA). Organizations in this hub have their headquarters located in European Union (EU), Europe; notable events and people located in European Union (EU) are also included. The second largest was Okta ’s $6.5 billion acquisition of Bellevue, … BCLS Acquisition Corp. Closed. A special purpose acquisition company (SPAC; / s p æ k /), also known as a "blank check company" is a shell corporation listed on a stock exchange with the purpose of acquiring a private company, thus making it public without going through the traditional initial public offering process. Overview. > EBAC IS THE FIRST HEALTHCARE SPAC TO EXCLUSIVELY FOCUS ON EUROPEAN BIOTECH > EDUARDO BRAVO TO JOIN LSP AS A PARTNER AND BECOME EBAC’S CEO LSP, the leading European life sciences investor, today announces the closing of the upsized $120 million Nasdaq IPO of European Biotech Acquisition Corporation (EBAC). A blank check company: 2021-02-17: European Biotech Acquisition Corp. Amsterdam, NETHERLANDS: $120.0 mil. November 30, 2020. Add to Contacts. N/A. 2020 review of the key events for the European biotech landscape of public companies. San Jose software company Apigee began trading on the Nasdaq on April 24, 2015. A blank check company: 2021-02-17: European Biotech Acquisition Corp. Amsterdam, NETHERLANDS: $120.0 mil. Shares of special purpose acquisition company Mudrick Capital Acquisition Corporation II (MUDS) are climbing more than 11% Tuesday morning following the company's decision to merge with trading cards company Topps. SHANGHAI, Oct. 22, 2020 /PRNewswire/ -- Longevity Acquisition Corporation (NASDAQ: LOAC) (the "Company" or … Get detailed information on EUROPEAN BIOTECH ACQUISITION CORP (EBACU.NQ) including stock quotes, financial news, historical charts, company background, company fundamentals, company financials, insider trades, annual reports and historical prices in the Company Factsheet. He is the CEO of EBAC (European Biotech Acquisition Corporation), a Nasdaq’s listed SPAC sponsored by LSP with focus on European biotech companies. Upcoming IPOs | Recent IPOs of SPAC units | Recent IPOs of warrants | Recent IPOs of other securities | Recently launched ETFs. Eduardo Bravo will join LSP as a Partner and become EBAC’s CEO. Biotech IPO Calendar. European Biotech Acquisition Corp. (the "Company") announced today that, commencing May 6, 2021, holders of the units sold in the Company's initial public offering of 12,000,000 units, completed on March 18, 2021, and the subsequent sale of an additional 754,784 units upon partial-exercise of the underwriters' over-allotment option, completed on May 3, 2021, may elect … Aldel Financial Inc. Warrants, each whole warrant entitles the holder thereof to purchase one share of Class A common stock at a price of $11.50 per s. And on Tuesday, shares of … Toronto Stock Exchange, TSX Venture Exchange TMX Group today announced its financing activity on Toronto Stock Exchange and TSX Venture Exchange for April 2021 . Panacea Acquisition Corp II prices its initial public offering of 15M shares at $10 per share to trade under the ticker symbol "PANA". The largest deal announced in the month of February was the acquisition of PRA Health Sciences ( PRAH) by ICON Public Limited Company ( ICLR) for $12 billion. The units will be listed on The Nasdaq Capital Market LLC (the "Nasdaq") and trade under the symbol "ORIAU" beginning May 13, 2021.. Each unit consists of one of the Company… DUBLIN – Last year was yet another banner year for European biotechnology firms engaged in drug development. The U.S. initial public offering market is gearing up for a dizzying week at least by deal number, with 15 companies expected to raise a total of $2.5 billion. European Biotech Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. Get detailed information on CAMDEN NATIONAL CORPORATION (CAC.NQ) including stock quotes, financial news, historical charts, company background, company fundamentals, company financials, insider trades, annual reports and historical prices in the Company Factsheet. The blank check group is focused on purchasing a company in the biotechnology sector. This paperwork registers 10 million units for public trade. Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Jun 16, 2020 INTEL by Matt Cianci. EFFECTOR Therapeutics bugs out of an IPO, taking the SPAC path with Locust Walk. Startup mortgage lender Better HoldCo is going public via a merger with special purpose acquisition corporation (SPAC) Auroa Acquisition Corp. AURC, +0.05% in … The transaction includes $250 million from FinTech V’s trust. This list of companies in European Union (EU) in the Biotechnology space that have been acquired provides data on their funding history, investment activities, and acquisition trends. Closed. SPAC’s have been around for a long time, but have become increasingly popular in recent years. HealthCor Catalio Acquisition Corp. started trading shares Wednesday as it raised $180 million in an initial public offering. Files for $100M IPO. June 2017. The UK-based company is expected to be valued at between £4 billion and £7 billion, the Financial Times reported. Therapeutics Acquisition Corp. Profile. MedCity News and Bright.MD. So far, 36 biotech companies have gone public this year as money has flowed into the sector. A SPAC (Special Purpose Acquisition Company) is a company created solely to buy another firm and take it public — an alternative to a traditional IPO. 86. 2A, Part 77.This act, also known as the Truth in Securites Act was inacted to bring greater transparency to securities. To learn more about investing with Masterworks, use this link to bypass the waitlist of 20,000 people today. E uropean Biotech Acquisition, a blank check company formed by LSP targeting the life sciences industry in Europe, raised $120 million by offering 12 million units at $10. The company offered 2 million more units than anticipated. Each unit consists of one share of common stock and one-third of a warrant, exercisable at $11.50. Amsterdam, March 18, 2021 - LSP, the leading European life sciences investor, today announces the closing of the upsized $120 million Nasdaq IPO of European Biotech Acquisition Corporation (EBAC). Its initial focus was battery packs for Chinese vehicles, but it shifted to manufacturing cars in 2014. Multinational law firm Pinsent Masons has advised AIM listed biotech company 4D Pharma plc (4D) on its acquisition of Longevity Acquisition Corporation, a special-purpose acquisition company (SPAC) listed on NASDAQ. A newly organized blank check company: 2021-02-17: Hayward Holdings, Inc. Berkeley Heights, NJ: $880.1 mil. European Sustainable Growth Acquisition Corp. 125 1/2 1/4/21 Greenwich, CT Clean Tech 16. Recent IPOs of Warrants. Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share. Sutro Biopharma – $85 Million IPO. European Biotech Acquisition Corp. announced the pricing of its $120 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “EBACU,” Tuesday, March 16.